Rhynchosia pyramidalis

Rhynchosia pyramidalis · Accepted scientific name

Scientific literature: Sparse (74 studies) · ★★☆☆☆

, scientifically known as Rhynchosia pyramidalis, is a fascinating medicinal plant belonging to the Fabaceae family. Often found in tropical regions, it is traditionally valued for its unique bioactive properties. This study explores its botanical characteristics, therapeutic potential, and the traditional healing practices associated with its various medicinal applications.

Family
Not available
Native range
Northern America
Parts used
Not available
Common names
Not available
Scientific synonyms
Not available

Names and Synonyms

Scientific Names

Accepted name

Rhynchosia pyramidalis

Distribution

This plant exhibits a wide-ranging presence across various regions within the country of Mexico. Its distribution encompasses the central territories, covering much of the Mexico Central area. Additionally, it can be found extending into the Mexico Northeast and Mexico Gulf regions. The species is also documented throughout the Mexico Northwest, demonstrating significant ecological flexibility. Finally, its geographical reach concludes with its occurrence in the Mexico Southwest.

Region Area
Mexico Mexico Central
Mexico Mexico Northeast
Mexico Mexico Gulf
Mexico Mexico Northwest
Mexico Mexico Southwest
Mexico Mexico Southeast
Central America Belize
Central America El Salvador
Central America Guatemala
Central America Honduras

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Ecology

The ecology of Rhynchosia pyramidalis is characterized by its ability to inhabit a broad altitudinal spectrum, allowing it to colonize diverse topographical landscapes. This species can be found across a significant vertical gradient, ranging from sea level (0 m AMSL) up to a maximum elevation of 1550 m AMSL. This expansive elevational range suggests a high degree of adaptability to varying climatic conditions, temperature fluctuations, and atmospheric pressures encountered between coastal lowlands and montane environments. Such ecological plasticity enables the plant to establish itself in a variety of habitats within this altitude window, likely interacting with diverse soil compositions and moisture regimes found throughout these different elevations.

Elevational range max:
1550 m AMSL
Elevational range min:
0 m AMSL

Morphology

The morphology of Rhynchosia pyramidalis is characterized by a woody structure and a growth form classified as a herb. It functions as an independent organism rather than a parasite, maintaining a terrestrial existence across its habitat. While it lacks aquatic or semiaquatic tendencies, its physical architecture is defined by a liana habit, acting as an obligatory climber that requires external support to ascend. It does not exhibit epiphytic characteristics, remaining strictly terrestrial in its ecological positioning.

Aquatic :
terrestrial
Climber :
liana
Climber :
obligatory
Epiphyte :
terrestrial
Growth form :
herb
Parasite :
independent
Woodiness :
woody

Physiology

The physiology of Rhynchosia pyramidalis is characterized by its utilization of the C3 photosynthetic pathway, which dictates its metabolic processes and carbon fixation mechanisms. In this pathway, the initial fixation of atmospheric carbon dioxide is catalyzed by the enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), leading to the direct production of three-carbon molecules such as 3-phosphoglycerate. This biochemical strategy implies that the plant's energy conversion efficiency and gas exchange rates are closely tied to environmental variables, particularly temperature and moisture availability, as the C3 process is susceptible to photorespiration under high-temperature or water-limiting conditions. Consequently, its physiological performance and biomass accumulation are governed by the efficiency of these C3 metabolic cycles within the leaf tissues.

Photosynthetic pathway :
C3

Reproduction

The reproduction of Rhynchosia pyramidalis is characterized by a diverse range of dispersal syndromes, encompassing anemochorous, zoochorous, autochorous, hydrochorous, and unspecialized methods. Among these strategies, the zoochorous syndrome plays a significant role in the movement of its seeds. The seeds produced by this species exhibit specific mass variations, with a recorded minimum seed mass of 0.05595 g and a maximum seed mass of 0.095 g. On average, the seed mass is approximately 0.07371 g, reflecting a consistent biological investment in the progeny required for successful colonization and survival.

Dispersal syndrome :
zoochorous
Seed mass max:
0.095 g
Seed mass mean:
0.07371 g
Seed mass min:
0.05595 g

Sources: Global Inventory of Floras and Traits (GIFT)

Chemicals

Rhynchosia pyramidalis has 2 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include genistein, hydroxygenistein.

Chemicals reported in Rhynchosia pyramidalis
Chemical Supporting sources Consensus
genistein 1 supporting sources ★☆☆☆☆
hydroxygenistein 1 supporting sources ★☆☆☆☆

genistein

  1. Dr. Duke

hydroxygenistein

  1. Dr. Duke

Activities

Rhynchosia pyramidalis has 72 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include Abortifacient, Aldose-Reductase-Inhibitor, Alpha-Reductase-Inhibitor, Antiaggregant, Antiangiogenic.

Activities reported in Rhynchosia pyramidalis
Activity Supporting sources Consensus
Abortifacient 1 supporting sources ★☆☆☆☆
Aldose-Reductase-Inhibitor 1 supporting sources ★☆☆☆☆
Alpha-Reductase-Inhibitor 1 supporting sources ★☆☆☆☆
Antiaggregant 1 supporting sources ★☆☆☆☆
Antiangiogenic 1 supporting sources ★☆☆☆☆
Antiatherosclerotic 1 supporting sources ★☆☆☆☆
Anticancer (Breast) 1 supporting sources ★☆☆☆☆
Anticarcinomic (Breast) 1 supporting sources ★☆☆☆☆
Anticlimacteric 1 supporting sources ★☆☆☆☆
Antiendoccytotic 1 supporting sources ★☆☆☆☆

Abortifacient

  1. Dr. Duke

Aldose-Reductase-Inhibitor

  1. Dr. Duke

Alpha-Reductase-Inhibitor

  1. Dr. Duke

Antiaggregant

  1. Dr. Duke

Antiangiogenic

  1. Dr. Duke

Antiatherosclerotic

  1. Dr. Duke

Anticancer (Breast)

  1. Dr. Duke

Anticarcinomic (Breast)

  1. Dr. Duke

Anticlimacteric

  1. Dr. Duke

Antiendoccytotic

  1. Dr. Duke